| 1 |
Chemo- and Regioselective Lysine Modification on Native Proteins
María João Matos, Bruno L. Oliveira, Nuria Martínez‐Sáez et al. · Journal of the American Chemical Society
Open access |
23 Feb 2018 |
314 |
| 2 |
Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents
Barbara Bernardim, Pedro M. S. D. Cal, María João Matos et al. · Nature Communications
Open access |
26 Oct 2016 |
191 |
| 3 |
Chemoselective Installation of Amine Bonds on Proteins through Aza-Michael Ligation
Allyson M. Freedy, María João Matos, Omar Boutureira et al. · Journal of the American Chemical Society
Open access |
5 Dec 2017 |
106 |
| 4 |
Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin
Esben Gjerløff Wedebye Schmidt, Michael Lykke Hvam, Filipa Antunes et al. · Journal of Biological Chemistry
Open access |
21 Jun 2017 |
81 |
| 5 |
Synthesis and Biological Evaluation of Homogeneous Thiol‐Linked NHC*‐Au‐Albumin and ‐Trastuzumab Bioconjugates
María João Matos, Carlos Labão‐Almeida, Claire T. Sayers et al. · Chemistry - A European Journal
Open access |
5 May 2018 |
48 |
| 6 |
FcRn overexpression in human cancer drives albumin recycling and cell growth; a mechanistic basis for exploitation in targeted albumin-drug designs
Maja Thim Larsen, Ole Aalund Mandrup, Karen Kræmmer Schelde et al. · Journal of Controlled Release
|
4 Mar 2020 |
44 |
| 7 |
Cellular recycling-driven in vivo half-life extension using recombinant albumin fusions tuned for neonatal Fc receptor (FcRn) engagement
Maja Thim Larsen, Helen Rawsthorne, Karen Kræmmer Schelde et al. · Journal of Controlled Release
|
29 Aug 2018 |
38 |
| 8 |
An albumin-mediated cholesterol design-based strategy for tuning siRNA pharmacokinetics and gene silencing
Konrad Bieńk, Michael Lykke Hvam, Malgorzata Maria Pakula et al. · Journal of Controlled Release
|
12 Apr 2016 |
38 |
| 9 |
One-pot thiol–amine bioconjugation to maleimides: simultaneous stabilisation and dual functionalisation
Archie Wall, Alfie Wills, Nafsika Forte et al. · Chemical Science
Open access |
2020 |
33 |
| 10 |
Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products
Clémentine Mirabel, Eduard Puente‐Massaguer, Anna del Mazo-Barbara et al. · Journal of Translational Medicine
Open access |
24 Oct 2018 |
31 |
| 11 |
Albumin-based Drug Delivery Using Cysteine 34 Chemical Conjugates–Important Considerations and Requirements
Mikael Bjerg Caspersen, Matthias Kuhlmann, Karl Nicholls et al. · Therapeutic Delivery
|
30 May 2017 |
28 |
| 12 |
Engineered Polymer–Transferrin Conjugates as Self-Assembling Targeted Drug Delivery Systems
Hiteshri Makwana, Francesca Mastrotto, Johannes Pall Magnusson et al. · Biomacromolecules
Open access |
28 Mar 2017 |
28 |
| 13 |
Site-selective conjugation of an anticoagulant aptamer to recombinant albumins and maintenance of neonatal Fc receptor binding
Julie S. Schmøkel, Anders Voldum, Georgia Tsakiridou et al. · Nanotechnology
|
31 Mar 2017 |
26 |
| 14 |
A new class of recombinant human albumin with multiple surface thiols exhibits stable conjugation and enhanced FcRn binding and blood circulation
Karen Kræmmer Schelde, Karl Nicholls, Frederik Dagnæs‐Hansen et al. · Journal of Biological Chemistry
Open access |
3 Jan 2019 |
23 |
| 15 |
Glucagon-like Peptide 1 Conjugated to Recombinant Human Serum Albumin Variants with Modified Neonatal Fc Receptor Binding Properties. Impact on Molecular Structure and Half-Life
Jens T. Bukrinski, Pernille Sønderby, Filipa Antunes et al. · Biochemistry
Open access |
11 Aug 2017 |
23 |
| 16 |
Optimised approach to albumin–drug conjugates using monobromomaleimide-C-2 linkers
Archie Wall, Karl Nicholls, Mikael Bjerg Caspersen et al. · Organic & Biomolecular Chemistry
Open access |
2019 |
21 |
| 17 |
Co-expression and purification of the RadA recombinase with the RadB paralog from Haloferax volcanii yields heteromeric ring-like structures
Bushra Bano Patoli, Jody A. Winter, Atif A. Patoli et al. · Microbiology
Open access |
26 Oct 2017 |
9 |
| 18 |
Cathepsin B Processing Is Required for the In Vivo Efficacy of Albumin–Drug Conjugates
Barbara Bernardim, João Conde, Tuuli A. Hakala et al. · Bioconjugate Chemistry
Open access |
12 Feb 2024 |
8 |
| 19 |
Aggregate Suppression of Recombinant Human Serum Albumin (HSA) by Adenosine Triphosphate (ATP)
Nikita Vekaria, Shuyuan Tan, Eleonora Cerasoli et al. · Molecular Pharmaceutics
Open access |
28 Aug 2025 |
5 |
| 20 |
Synthetic Ligand Affinity Chromatography Purification of Human Serum Albumin and Related Fusion Proteins
Sharon Williams, Phil Morton, Dev Baines · Methods in molecular biology
Book chapter |
31 Oct 2020 |
3 |
| 21 |
Fusion of IgG antibodies to albumin inhibits transport across the placenta
Jeannette Nilsen et al. · Science Immunology
|
14 Aug 2026 |
1 |
| 22 |
RECOMBINANT HUMAN ALBUMIN IMPROVES ERYTHROBLAST EXPANSION AND MATURATION IN hiPSC-DERIVED ERYTHROID CULTURES
L. Cacho Cirera, S. Huertas Torres, L. Miquel-Serra et al. · Cytotherapy
|
30 Apr 2026 |
0 |
| 23 |
Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy
Phil Morton, Shanya Jiang · Cell and Gene Therapy Insights
Open access |
3 Mar 2025 |
0 |
| 24 |
Has COVID-19 changed the future of pharmaceutical regulation?
H. Sutherland Edwards · Journal of Regulatory Science
Open access |
15 Jul 2021 |
0 |